{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:36:36Z","timestamp":1792647396794,"version":"4.5.0"},"reference-count":40,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2020,6,2]]},"DOI":"10.1080\/13543784.2020.1763953","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T08:26:51Z","timestamp":1588235211000},"page":"547-554","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":54,"title":["Risuteganib\u2014a novel integrin inhibitor for the treatment of non-exudative (dry) age-related macular degeneration and diabetic macular edema"],"prefix":"10.1080","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4485-1678","authenticated-orcid":false,"given":"Lincoln T.","family":"Shaw","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Science, University of Chicago, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mackin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, University of Chicago, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reanna","family":"Shah","sequence":"additional","affiliation":[{"name":"Duke University, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siona","family":"Jain","sequence":"additional","affiliation":[{"name":"Phillips Exeter Academy, Exeter, NH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prisha","family":"Jain","sequence":"additional","affiliation":[{"name":"Phillips Exeter Academy, Exeter, NH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Nayak","sequence":"additional","affiliation":[{"name":"University of Chicago, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seenu M.","family":"Hariprasad","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, University of Chicago, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(13)70145-1"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1007\/164_2016_36"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-306972"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2016.61918"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddx228"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.3109\/08820538.2011.570849"},{"issue":"3","key":"cit0007","volume":"9","author":"Shin ES","journal-title":"J Ophthalmic Vis Res"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-019-1276-5"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.3945\/an.116.013177"},{"issue":"19","key":"cit0010","first-page":"2005\u20132015.","volume":"309","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"cit0011","first-page":"1417\u20131436.","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2013.6636"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20160229-09"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000726"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.04.024"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.04.030"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2018.11.001"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.03.057"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.19198.1"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0584-y"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-016-0816-5"},{"key":"cit0022","unstructured":"A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE). NIH\/U.S. National Library of Medicine. ClinicalTrials.gov. 2019 [cited 2019 Nov 25]. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03622580"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.118.248427"},{"issue":"9","key":"cit0024","first-page":"1961","volume":"59","author":"Edwards D","year":"2018","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"cit0025","first-page":"September:30","author":"Quiroz-Mercado H","journal-title":"Retina Today"},{"key":"cit0026","unstructured":"Risuteganib (LUMINATE\u00ae): potential Paradigm Shift In the Treatment of Oxidative Stress-Induced DME. Allegro Ophthalmics, LLC, 2018 [Last accessed 2019 Nov 25. Available at: https:\/\/ois.net\/wp-content\/uploads\/2018\/10\/CompanyShowcase_Allegro.pdf"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(00)00140-5"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.18.9764"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00644-16"},{"issue":"4","key":"cit0030","first-page":"273","volume":"5","author":"Ramakrishnan V","year":"2006","journal-title":"J Exp Ther Oncol"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141618"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.10"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2007.11.001"},{"key":"cit0034","unstructured":"The Scoop on Anti-Integrin Therapy for DME. PU Dugel. Retina Today, 2019 [cited 2019 Nov 25. Available at: http:\/\/retinatoday.com\/2019\/02\/the-scoop-on-anti-integrin-therapy-for-dme"},{"key":"cit0035","unstructured":"The Promise of Integrin Receptors for Treating Vitreoretinal Disorders. V Gonzalez. Retina Today, 2016 [Last accessed 2019 Nov 25. Available at: http:\/\/retinatoday.com\/2016\/08\/the-promise-of-integrin-receptors-for-treating-vitreoretinal-disorders"},{"key":"cit0036","unstructured":"Allegro Ophthalmics Announces Positive Topline Vision Results of Phase 2 Study Evaluating Risuteganib in Patients with Intermediate Dry Age-Related Macular Degeneration. Allegro Ophthalmics, LLC, 2019 [cited 2019 Nov 25]. Available at: https:\/\/www.allegroeye.com\/allegro-ophthalmics-expands-its-anti-integrin-portfolio-with-new-front-of-the-eye-drug-candidate-alg-1007-for-the-treatment-of-dry-eye-disease-3-2-2\/"},{"key":"cit0037","unstructured":"Phase 2 Randomized Clinical Trial of Luminate\u00ae as Compared to Avastin\u00ae in the Treatment of Diabetic Macular Edema. NIH\/U.S. National Library of Medicine. ClinicalTrials.gov, 2019 [cited 2019 Nov 25]. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02348918"},{"issue":"9","key":"cit0038","volume":"59","author":"Quiroz-Mercado H","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"cit0039","unstructured":"Allegro Ophthalmics Announces Positive Topline Results from DEL MAR Phase 2b Stage 2 Trial Evaluating Luminate\u00ae in Patients with Diabetic Macular Edema. Allegro Ophthalmics, LLC. 2017 [cited 2019 Nov 25]. Available at: https:\/\/www.allegroeye.com\/allegro-ophthalmics-announces-positive-topline-results-from-del-mar-phase-2b-stage-2-trial-evaluating-luminate-in-patients-with-diabetic-macular-edema-2\/"},{"key":"cit0040","unstructured":"Allegro Ophthalmics Prepares To Take Lead Compound Risuteganib To Phase 3, Appoints New CEO. Allegro Ophthalmics, LLC. 2018 [cited 2019 Nov 25]. Available at: https:\/\/www.allegroeye.com\/allegro-ophthalmics-prepares-to-take-lead-compound-risuteganib-to-phase-3-appoints-new-ceo\/"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2020.1763953","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T05:18:20Z","timestamp":1620451100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2020.1763953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,2]]}},"alternative-id":["10.1080\/13543784.2020.1763953"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2020.1763953","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-01-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}